title: Ranibizumab treatment for retinal angiomatous proliferation lesions: a case report with life-long expectancy (seven years) follow-up.
authors.affiliation: Department of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland.
authors.forename: G
authors.initials: G
authors.lastname: Donati
authors.affiliation: Centre Ophtalmologique de Rive, Geneva, Switzerland.
authors.forename: C J
authors.initials: CJ
authors.lastname: Pournaras
mesh_terms: D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008017:Life Expectancy; D008137:Longitudinal Studies; D000069579:Ranibizumab / Q000008:administration & dosage*; D015861:Retinal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000187:drug effects; D057135:Wet Macular Degeneration / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab